𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: Current concepts

✍ Scribed by Jonathan S. Levine; Robert Burakoff

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
82 KB
Volume
13
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

✦ Synopsis

Ulcerative colitis and Crohn's disease both confer an increased risk of developing colorectal cancer. The use of 5-aminosalicylate as a remission-inducing agent has been long accepted. Its use as a potential chemoprophylactic agent has been proposed and is used by some practitioners. This review examines the most recent data on 5-aminosalicylate as a chemoprophylactic drug as well as ursodeoxycholic acid, folic acid, azathioprine, and 6-mercaptopurine.

πŸ“œ SIMILAR VOLUMES

Two distinct groups of colorectal cancer
Two distinct groups of colorectal cancer in inflammatory bowel disease
✍ Stephan Brackmann; Solveig Norheim Andersen; Geir Aamodt; Borghild Roald; FrΓΈydi πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 192 KB

## Background: The histological variability in colitis-associated colorectal cancer (crc in inflammatory bowel disease [ibd]) and the association to clinical factors is unknown. ## Methods: In population-based material including 67 patients with crc in ibd, histopathology of the cancers and tissu

Differential MicroRNA expression tracks
Differential MicroRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer
✍ Ziad Kanaan; Shesh N. Rai; M. Robert Eichenberger; Christopher Barnes; Amy M. Dw πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 486 KB πŸ‘ 1 views

## One of the most serious complications faced by patients with inflammatory bowel disease (IBD) is the potential development of colorectal cancer (CRC). There is a compelling need to enhance the accuracy of cancer screening of IBD patients. MicroRNAs (miRNAs) are small nonprotein-coding RNAs that

Current understanding of fungal microflo
Current understanding of fungal microflora in inflammatory bowel disease pathogenesis
✍ David Underhill; Jonathan Braun πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 99 KB

Inflammatory bowel diseases are a current and growing public health problem, with a prevalence that appears to be increasing in most countries and cultures. While most research into the triggering phenomenon has focused on the interaction between commensal bacteria and inflammatory bowel disease, en

Widespread but not localized neoplasia i
Widespread but not localized neoplasia in inflammatory bowel disease worsens the prognosis of colorectal cancer
✍ Stephan Brackmann; Geir Aamodt; Solveig Norheim Andersen; Borghild Roald; FrΓΈydi πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 209 KB

## Background: Patients with inflammatory bowel disease (ibd) are at increased risk of colorectal cancer (crc). recently, new phenotypes of crc in ibd have been suggested. studies of the prognosis of crc in ibd have shown conflicting results. the aim of the study was to analyze factors for prognosi

Role of chromoendoscopy in colon cancer
Role of chromoendoscopy in colon cancer surveillance in inflammatory bowel disease
✍ Henrik Thorlacius; Ervin Toth πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 2 views

Inflammation in the intestine is a well-known risk factor for neoplastic changes in the mucosa. In fact, it has been shown that long-standing ulcerative colitis and colonic Crohn's disease have a significantly increased risk for developing colorectal cancer, although the estimates vary widely betwee